Event context and recent price performance

STAAR Surgical (STAA) has drawn investor attention after a recent move in its share price, with the stock up 4.6% over the past day and 12.9% over the past week.

Over the past month, the stock shows a 9.5% gain, while the past 3 months reflect a 15.6% decline. This sets up a mixed recent performance profile for investors to assess.

At a share price of $20.21, STAAR Surgical’s recent gains sit against a weaker longer run, with short term share price momentum improving while multi year total shareholder returns remain negative.

If you are curious about other names in high growth areas of healthcare, this is a good moment to scan 36 healthcare AI stocks.

With STAAR Surgical trading at $20.21, close to analyst targets yet flagged with an intrinsic discount of about 15%, the key question is simple: is the market overlooking value here or already factoring in all future growth?

Most Popular Narrative: 24% Undervalued

At $20.21, the most followed narrative sets STAAR Surgical’s fair value at $26.56, implying a material discount that hinges on a specific earnings turnaround story.

Stronger projected growth and margin expansion underpin the recent upward adjustment in fair value estimates. This suggests that core execution in the underlying business is tracking slightly ahead of prior expectations.

Want to see what is behind that earnings shift and fair value gap? The narrative focuses on accelerating revenue, improving margins and a richer future profit multiple. Curious which assumptions really move the model?

Result: Fair Value of $26.56 (UNDERVALUED)

However, this depends on China stabilising. Any prolonged weakness there, or sustained cost cutting that undercuts growth investment, could quickly call that underpriced story into question.

Another View: Market Multiple Sends a Different Signal

The DCF work points to value upside, yet the price tag tells a different story. STAAR Surgical trades on a P/S of 4.2x, richer than both the US Medical Equipment average and the peer average of 2.6x, and above a fair ratio of 3.1x. That gap suggests valuation risk if sentiment cools. This raises the question: which story do you trust more, the model or the market?

Next Steps

If this mix of optimism and caution feels familiar, now is the time to look at the numbers yourself and decide where you stand. To see what the market is currently excited about, review the 2 key rewards.

Looking for more investment ideas?

If STAAR Surgical has sharpened your focus, do not stop here. Broader context from other opportunities can help you build a more resilient, well balanced portfolio.

• Spot potential value candidates early by scanning 58 high quality undervalued stocks that combine quality fundamentals with prices the market may not fully appreciate.
• Strengthen your income stream by reviewing 13 dividend fortresses that pair higher yields with more established payout histories.
• Prioritise resilience by checking 68 resilient stocks with low risk scores where balance sheets and risk scores are designed to keep surprises in check.

Take a few minutes now to explore these ideas, otherwise you risk overlooking opportunities that could suit your goals just as well as STAAR Surgical.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.